Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
GenMark Diagnostics, Inc. (GNMK) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2022 SC 13G/A Consonance Capital Management LP reports a 0% stake in GENMARK DIAGNOSTICS INC
05/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/03/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
04/28/2021 EFFECT Form EFFECT - Notice of Effectiveness:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
04/22/2021 4 Giles Lisa M. (Director) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Unknown transaction of 81,572 shares @ $24.05, valued at $2M
Unknown transaction of 5,500 shares @ $24.05, valued at $132.3k
Disposed/sold 19,062 options to buy @ $13.17, valued at $251k
04/22/2021 4 Kagnoff Michael (Director) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Unknown transaction of 137,319 shares @ $24.05, valued at $3.3M
Disposed/sold 19,062 options to buy @ $13.17, valued at $251k
04/22/2021 4 Fox James (Director) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Unknown transaction of 182,017 shares @ $24.05, valued at $4.4M
Unknown transaction of 81,085 shares @ $24.05, valued at $2M
04/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/22/2021 4 Stevenson Wade R. (SVP, North America Sales) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Unknown transaction of 50,000 shares @ $24.05, valued at $1.2M
04/22/2021 4 Shaw Christine (VP, Assay Development) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Unknown transaction of 101,324 shares @ $24.05, valued at $2.4M
Disposed/sold 17,500 options to buy @ $0
04/22/2021 4 Winkler Sarah Hollis (VP, Human Resources) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Unknown transaction of 147,502 shares @ $24.05, valued at $3.5M
Disposed/sold 6,668 options to buy @ $0
Disposed/sold 33,334 options to buy @ $0
Disposed/sold 12,500 options to buy @ $0
04/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/22/2021 4 Jensen Tyler (SVP, Engineering and Tech Dev) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Unknown transaction of 212,249 shares @ $24.05, valued at $5.1M
Disposed/sold 11,668 options to buy @ $0
Disposed/sold 40,000 options to buy @ $0
Disposed/sold 12,500 options to buy @ $0
04/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/22/2021 4 Chohan Abdul (SVP Operations) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Unknown transaction of 63,750 shares @ $24.05, valued at $1.5M
Disposed/sold 12,500 options to buy @ $0
04/22/2021 4 Stier Eric (SVP & General Counsel) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Unknown transaction of 275,974 shares @ $24.05, valued at $6.6M
Disposed/sold 15,832 options to buy @ $0
Disposed/sold 35,000 options to buy @ $0
Disposed/sold 12,500 options to buy @ $0
Disposed/sold 30,000 options to buy @ $8.5, valued at $255k
Disposed/sold 62,000 options to buy @ $12.3, valued at $762.6k
Disposed/sold 55,550 options to buy @ $13.17, valued at $731.6k
04/22/2021 4 Harkins Michael John (SVP, Sales) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Unknown transaction of 144,214 shares @ $24.05, valued at $3.5M
Disposed/sold 38,334 options to buy @ $0
Disposed/sold 7,500 options to buy @ $0
04/22/2021 4 Gleeson Michael (SVP, Corp. Accounts) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Unknown transaction of 421,383 shares @ $24.05, valued at $10.1M
Unknown transaction of 30,069 shares @ $24.05, valued at $723.2k
Disposed/sold 20,213 options to buy @ $10.89, valued at $220.1k
Disposed/sold 62,046 options to buy @ $12.3, valued at $763.2k
Disposed/sold 55,674 options to buy @ $13.17, valued at $733.2k
Disposed/sold 16,668 options to buy @ $0
Disposed/sold 38,334 options to buy @ $0
Disposed/sold 12,500 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy